---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "H7tUNOSd1Oy5mpHZrwvE3xehvvb9nPPGM5g8u3LnfuA6cwey0gWUy0IDwiJmrpPdLFUp0Hkv/ehuENzNaTrd4h7XdoQnXggmwcIf+4dsOyU9TUeds7cjBVRhaBxjaJRqIgiVcdna0DltcI8ISf8xtCh3tLgsv3ZaEomhZFuuSddh3yaMRp6W4mWf5nV32WlOtHBOS+URrqK2NNKlPOVVEUsjvnk1VFhg+zrc+R/uTOcWWfdZ4Z0JupBJr6Y/oe96KaP7Gx3+reQE2yBboFmMxYRxICdC4sB0dENmn+n5FYan3wPdhmzKLvw5B7n6kRuiSpHZtF/rMcOUj5JFSgjtd76vJuJnmfBxyvPcA/gtF0U=;e/G7DkphEyZGgkPitsFMfA=="
---

